BBWI Bath & Body Works, Inc. Insider Trading

Director Nash bought 10,000 BBWI shares at $15.58; stock -58.9% from 52-week high, 5 other insiders buying concurrently.

Director Sarah E Nash purchased 10,000 shares at $15.58 on 2025-11-24, bringing her holdings to 285,522 shares (+3.6% net change). The transaction occurs as Bath & Body Works trades at $16.90, down 58.9% from its 52-week high of $41.08 and down 46.4% over the past 90 days. The company's fundamentals show annual revenue growth of -1.6% and a low P/E of 4.96, though it generated $77.0M in net income on $1.6B quarterly revenue. Notably, this buy is part of a cluster pattern: 5 other insiders also purchased shares within the past 14 days, suggesting coordinated confidence at depressed valuations. Nash's own cross-ticker trading record shows strong execution on sell timing (100% well-timed rate on prior sells with -30.3% average 90-day return), and her prior BBWI trade in June 2024 was similarly well-timed, adding credibility to her current accumulation decision amid significant price deterioration.

Director Symancyk purchases 22,500 BBWI shares at $15.58; holdings surge 125.8%; 5 other insiders also bought in 14 days amid 46.4% 90-day decline.

Director James Kevin Symancyk increased his stake in Bath & Body Works by 125.8%, purchasing 22,500 shares at $15.58 and raising holdings to 40,379 shares. This transaction is part of a cluster pattern, with 5 other insiders also buying within the past 14 days. The stock trades -58.9% from its 52-week high of $41.08 and has declined 46.4% over the past 90 days, suggesting the purchase occurred during a sustained period of weakness. The company's fundamentals show a modest P/E of 4.96 and recent net income of $77,000,000 on revenue of $1,594,000,000, though annual revenue growth stands at -1.6%. The multi-insider buying cluster during a significant drawdown from recent highs, combined with the director's substantial increase in personal ownership, warrants careful attention to the underlying drivers of this coordinated activity.

Director Voskuil buys 20,000 BBWI shares at $15.04; holdings surge to 33,925; cluster pattern with 5 other insiders buying within 14 days

Director Steven E Voskuil purchased 20,000 shares at $15.04, increasing his holdings by 143.6% to 33,925 shares, in a period when BBWI stock has declined sharply: -42.4% over 30 days and -50.4% over 90 days, trading -62.1% below its 52-week high of $41.08. This purchase occurs as part of a broader cluster pattern, with 5 other insiders also buying within the past 14 days. The company's fundamentals show revenue of $1,594,000,000.00 with net income of $77,000,000.00 and a P/E of 4.56, suggesting a compressed valuation relative to earnings. The concurrent buy activity across multiple insiders during a steep sell-off warrants examination of whether this represents a coordinated bottom-fishing opportunity or signals internal conviction about value at depressed levels.

Director Brady Lucy buys 3,469 shares of BBWI at $14.40; 5 other insiders also bought within 14 days amid -62.1% decline from 52-week high.

Brady Lucy, a director of Bath & Body Works, purchased 3,469 shares at $14.40 on 2025-11-21, increasing holdings to 17,481 shares. This transaction occurs as part of a cluster pattern: 5 other insiders also bought within the past 14 days. The stock is currently trading at $15.56, down 62.1% from its 52-week high of $41.08 and down 42.4% over the past 30 days, placing the purchase price near recent lows. The company's fundamentals show revenue of $1,594,000,000 with net income of $77,000,000, though annual revenue growth stands at -1.6% year-over-year. The convergence of multiple insider purchases during a period of sharp price depreciation warrants examination of whether this reflects opportunistic accumulation at depressed levels or broader confidence in the company's prospects.

Director Stephen D. Steinour bought 6,700 BBWI shares at $14.86; 5 other insiders bought within 14 days amid -62.1% 52-week decline.

Stephen D. Steinour, a director at Bath & Body Works, purchased 6,700 shares at $14.86 on 2025-11-21, increasing his holdings to 48,175 shares from 41,475 shares (+16.2% net change). This transaction occurs within a cluster pattern: 5 other insiders have also bought within the past 14 days. The timing is notable given that the stock trades at $15.56 currently, down -62.1% from its 52-week high of $41.08, with a steep -50.4% 90-day decline. The company's fundamentals show a P/E of 4.56 and annual revenue decline of -1.6%, though it generated $1.6B in quarterly revenue and $77.0M in net income. The coordinated buying activity among multiple insiders at depressed price levels merits examination as a potential indicator of management's assessment of valuation.

Director Hondal Francis buys 3,343 BBWI shares at $15.00; stock down 62.1% from 52-week high, 5 other insiders bought in past 14 days.

Hondal Francis, a director of Bath & Body Works, purchased 3,343 shares at $15.00 on 2025-11-21, increasing his holdings by 18.4% to 21,554 shares. This purchase coincides with the stock trading 62.1% below its 52-week high and down 42.4% over the prior 30 days. Notably, this transaction is part of a cluster pattern with 5 other insiders also buying within the past 14 days, suggesting coordinated confidence at the current price level. However, the company's fundamentals show mixed signals: revenue of $1,594,000,000 in the latest quarter with net income of $77,000,000, but annual revenue declined 1.6% year-over-year and the stock trades at a low P/E of 4.56, indicating either distress or significant undervaluation.

CEO Boswell purchases 6,000 BBWI shares at $29.64; current price $31.43, down 39.5% from 52-week high of $51.94.

Gina Boswell, Chief Executive Officer, acquired 6,000 shares at $29.64, increasing holdings to 242,987 shares. The purchase occurs while BBWI trades at $31.43, approximately 39.5% below its 52-week high of $51.94, yet 16.4% above its 30-day average. The company trades at a P/E of 8.14 with revenue of $1,526,000,000 and net income of $152,000,000, though annual revenue growth is negative at -1.7%. The transaction represents an open-market acquisition by the chief executive during a period of significant stock price erosion from recent highs.

Director Nash Sarah E sold 48,000 BBWI shares at $41.50 on 2024-06-18 for $1,992,120.00, reducing holdings by 24.3%.

Director Sarah E Nash sold 48,000 shares representing a 24.3% reduction in her holdings, executed at $41.50 while the stock has since declined 18.6% from its 52-week high of $51.94. The company shows declining annual revenue growth at -1.7% year-over-year and a tight P/E of 10.96, suggesting modest growth expectations embedded in the current valuation. The sale's timing relative to recent stock momentum (down 15.4% over 30 days and 9.5% over 90 days) provides no clear directional signal about management's forward outlook, but the substantial reduction in a director's position stake merits investor attention given the company's modest profitability ($87.0M net income on $1.4B quarterly revenue) and market conditions.